BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37209564)

  • 1. Neuroprotective effect of herbal extracts inhibiting soluble epoxide hydrolase (sEH) and cyclooxygenase (COX) against chemotherapy-induced cognitive impairment in mice.
    Kulkarni R; Mehta R; Goswami SK; Hammock BD; Morisseau C; Hwang SH; Mallappa O; Azeemuddin MM; Rafiq M; S N M
    Biochem Biophys Res Commun; 2023 Jul; 667():64-72. PubMed ID: 37209564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.
    Zhang YF; Sun CC; Duan JX; Yang HH; Zhang CY; Xiong JB; Zhong WJ; Zu C; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX
    Biomed Pharmacother; 2020 Jun; 126():109907. PubMed ID: 32114358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
    Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation.
    Dileepan M; Rastle-Simpson S; Greenberg Y; Wijesinghe DS; Kumar NG; Yang J; Hwang SH; Hammock BD; Sriramarao P; Rao SP
    Front Pharmacol; 2019; 10():1118. PubMed ID: 31611798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.
    Hye Khan MA; Hwang SH; Sharma A; Corbett JA; Hammock BD; Imig JD
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():40-7. PubMed ID: 27432695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.
    Zhang CY; Duan JX; Yang HH; Sun CC; Zhong WJ; Tao JH; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX
    FEBS J; 2020 Apr; 287(8):1666-1680. PubMed ID: 31646730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
    Pondugula SR; Majrashi M; Almaghrabi M; Ramesh S; Abbott KL; Govindarajulu M; Gill K; Fahoury E; Narayanan N; Desai D; Ren J; Nadar R; McElroy T; Moore T; Majeed M; Kalyanam N; Dhanasekaran M
    PLoS One; 2021; 16(6):e0252522. PubMed ID: 34081735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity.
    Jankiewicz WK; Barnett SD; Stavniichuk A; Hwang SH; Hammock BD; Belayet JB; Khan AH; Imig JD
    Front Pharmacol; 2021; 12():744776. PubMed ID: 34955823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.
    Wang F; Zhang H; Ma AH; Yu W; Zimmermann M; Yang J; Hwang SH; Zhu D; Lin TY; Malfatti M; Turteltaub KW; Henderson PT; Airhart S; Hammock BD; Yuan J; de Vere White RW; Pan CX
    Mol Cancer Ther; 2018 Feb; 17(2):474-483. PubMed ID: 29284644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
    Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
    Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease.
    Griñán-Ferré C; Companys-Alemany J; Jarné-Ferrer J; Codony S; González-Castillo C; Ortuño-Sahagún D; Vilageliu L; Grinberg D; Vázquez S; Pallàs M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810307
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Singh N; Barnych B; Morisseau C; Wagner KM; Wan D; Takeshita A; Pham H; Xu T; Dandekar A; Liu JY; Hammock BD
    J Nat Prod; 2020 Dec; 83(12):3689-3697. PubMed ID: 33320645
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase.
    Xu M; Hao H; Jiang L; Long F; Wei Y; Ji H; Sun B; Peng Y; Wang G; Ju W; Li P
    Phytomedicine; 2015 Apr; 22(4):444-51. PubMed ID: 25925966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development.
    Lakkappa N; Krishnamurthy PT; Yamjala K; Hwang SH; Hammock BD; Babu B
    J Pharm Biomed Anal; 2018 Feb; 149():457-464. PubMed ID: 29169114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.
    Gartung A; Yang J; Sukhatme VP; Bielenberg DR; Fernandes D; Chang J; Schmidt BA; Hwang SH; Zurakowski D; Huang S; Kieran MW; Hammock BD; Panigrahy D
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1698-1703. PubMed ID: 30647111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble epoxide hydrolase by extracts derived from inflammation-treating Chinese medicinal herbs.
    Shi DH; Xu C; Guo BX; Wang XT; Chen YX; Tan RX
    Phytother Res; 2008 Sep; 22(9):1264-8. PubMed ID: 18729246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease.
    Lee HT; Lee KI; Chen CH; Lee TS
    J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
    Pallàs M; Vázquez S; Sanfeliu C; Galdeano C; Griñán-Ferré C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32369955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
    Lakkappa N; Krishnamurthy PT; M D P; Hammock BD; Hwang SH
    Neurotoxicology; 2019 Jan; 70():135-145. PubMed ID: 30472438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.